A0A2R9BQM1 (A0A2R9BQM1_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)
Glycylpeptide N-tetradecanoyltransferase UniProtKBInterProSTRINGInteractive Modelling
496 aa; Sequence (Fasta) ;
4 identical sequences: Homo sapiens: P30419; Pongo abelii: A0A2J8UYT3; Pan troglodytes: H2QD84, A0A6D2WXT8
It is possible new templates exist for this target since these models were created.
Available Structures
43 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| HsNMT1 in complex with CoA and Myristoylated-GCSVSKKK octapeptide |
Heteromer O81223; P30419; | 100 | 1×COA; 1×GOL; 1×MYR; | |||
| HsNMT1 in complex with CoA and Myristoylated-GGCFSKPK octapeptide |
Heteromer P30419; Q96NN9; | 100 | 1×COA; 3×GOL; 1×CL; 1×MYR; | |||
| HsNMT1 in complex with both MyrCoA and HCPA substrate peptide GKQNSKLR |
Heteromer P30419; P84074; | 100 | 1×GOL; 1×MYA; | |||
| DeltaC3 C-terminal truncation of HsNMT1 in complex with MyrCoA and GDCFSKPR substrates |
Heteromer P30419; Q96NN9; | 100 | 1×MYA; 3×GOL; 1×CL; | |||
| HsNMT1 in complex with both MyrCoA and Acetylated-GKSFSKPR peptide reveals N-terminal Lysine Myrist… |
Heteromer P30419; Q96NN9; | 100 | 2×GOL; 1×COA; 1×MYR; | |||
| HsNMT1 in complex with both MyrCoA and Acetylated-GNCFSKPR substrates |
Heteromer P30419; Q96NN9; | 100.0 | 1×MYA; 1×CL; 2×GOL; | |||
| HsNMT1 in complex with both MyrCoA and GNCFSKRRAA substrates |
Heteromer P30419; Q96NN9; | 100 | 1×COA; 2×GOL; 1×CL; 1×MYR; | |||
| DeltaC2 C-terminal truncation of HsNMT1 in complex with MyrCoA and GNCFSKPR substrates |
Heteromer P30419; Q96NN9; | 100.0 | 1×GOL; 1×MYA; | |||
| C-terminal HsNMT1 deltaC3 truncation in complex with both MyrCoA and GNCFSKPR substrates |
Heteromer P30419; Q96NN9; | 100.0 | 1×GOL; 1×MYA; | |||
| HsNMT1 in complex with CoA and Myristoylated-GKSNSKLK octapeptide |
Heteromer P30419; P62166; | 100.0 | 2×GOL; 1×CL; 1×MYR; | |||
| Structure of Human NMT1 with products CoA and myristoyl-lysine peptide with acetylated N-terminus |
Heteromer P30419; P62330; | 100.0 | 2×COA; 4×GOL; 2×MYR; | |||
| Crystal structure of human N-myristoyltransferase 1 fragment (residues 109-496) bound to diacylated… |
Heteromer P30419; P62330; | 100 | 1×4PS; 1×MYR; 1×6NA; | |||
| Mutant of Human N-myristoyltransferase with bound myristoyl-CoA | homo-4-mer | 97.91 | 4×MYA; 4×MG; 9×GOL; | |||
| HsNMT1 in complex with both MyrCoA and GNCFSKAR inhibitor peptide | homo-2-mer | 100.0 | 2×COA; 4×GOL; 2×CL; 2×MYR; | |||
| HsNMT1 in complex with both MyrCoA and ACE-G-(L-ORN)SFSKPR | monomer | 100 | 1×GOL; 1×MYA; | |||
| HsNMT1 in complex with both MyrCoA and GNCFSKPR inhibitor peptide | monomer | 100 | 1×COA; 1×CL; 1×MG; 1×MYR; | |||
| HsNMT1 in complex with both MyrCoA and Ac-D-ORN-SFSKPR inhibitor peptide | monomer | 100 | 2×GOL; 1×CL; 1×MYA; | |||
| HsNMT1 in complex with both MyrCoA and GNCFSKPRVPTK inhibitor peptide | monomer | 100 | 1×COA; 2×GOL; 2×CL; 1×MYR; | |||
| HsNMT1 in complex with both MyrCoA and peptide AKSFSKPR | monomer | 100 | 2×GOL; 1×MYA; | |||
| HsNMT1 in complex with both MyrCoA and GNCFSKPR(NH2) inhibitor peptide | monomer | 100 | 1×COA; 2×GOL; 1×CL; 1×MYR; | |||
| HsNMT1 in complex with both MyrCoA and N-acetylated KSFSKPR peptide | monomer | 100 | 1×GOL; 1×COA; 1×MYA; 1×MYR; | |||
| HsNMT1 in complex with both MyrCoA and GNLLSKFR peptide | monomer | 100 | 1×COA; 2×GOL; 2×CL; 1×MG; 1×MYR; | |||
| HsNMT1 in complex with CoA and acetylated-NCFSKPK peptide | monomer | 100 | 1×MYA; 2×GOL; 1×CL; | |||
| HsNMT1 in complex with both MyrCoA and (DAB)SFSKPR inhibitor peptide | monomer | 100.0 | 1×MYA; 2×GOL; 2×CL; | |||
| HsNMT1 in complex with both CoA and Myr-ANCFSKPR peptide | monomer | 100 | 1×COA; 2×GOL; 1×MYR; | |||
| HsNMT1 in complex with both MyrCoA and peptide GGKSFSKPR | monomer | 100.0 | 1×GOL; 1×MYA; | |||
| HsNMT1 in complex with both MyrCoA and peptide N-Methylated-GNCFSKPR | monomer | 100 | 1×MYA; | |||
| Human NMT1 in complex with myristoyl-CoA and inhibitor IMP-917 | monomer | 100 | 1×MYA; 3×PO4; 1×9M2; 1×MG; 1×GOL; 1×DMS; | |||
| Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA | monomer | 100.0 | 1×MYA; | |||
| Human NMT1 in complex with myristoyl-CoA and inhibitor IMP-1031 | monomer | 100 | 1×MYA; 3×PO4; 1×MG; 1×9M8; | |||
| Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD… | monomer | 100 | 1×MYA; 1×X55; | |||
| Human N-myristoyltransferase (NMT1) with Myristoyl-CoA co-factor | monomer | 100 | 1×MYA; 1×MG; 1×CIT; 3×GOL; | |||
| Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD… | monomer | 100 | 1×MYA; 1×096; | |||
| Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor DDD… | monomer | 100 | 1×MYA; 1×646; | |||
| Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and IMP-1088 inhibitor bound | monomer | 100 | 1×MYA; 1×MG; 2×GOL; 1×KFK; | |||
| Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound | monomer | 100 | 1×BXN; 1×MYA; 1×MG; 2×GOL; | |||
| Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound | monomer | 100 | 1×EBK; 1×MYA; 1×MG; 1×GOL; | |||
| Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound | monomer | 100 | 1×MYA; 1×646; 1×MG; 1×CIT; 2×GOL; 3×CL; | |||
| Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and peptide bound | monomer | 100.0 | 2×GOL; 1×MYA; 1×GLY; 2×SER; 1×ASN; 3×LYS; 1×PRO; 1×MYR; 1×COA; | |||
| N-myristoyltransferase 1 (NMT) bound to myristoyl-CoA | monomer | 100.0 | 1×MYA; 1×CIT; | |||
| Human N-myristoyltransferase 1 (MNT1) with Myristoyl-CoA analogue X10 bound | monomer | 100.0 | 2×GOL; 1×94Q; 1×MG; | |||
| Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor bound | monomer | 100.0 | 1×31A; 1×MYA; 1×MG; 1×GOL; | |||
| Crystal structure of human myristoyl-CoA:protein N-myristoyltransferase. | monomer | 99.71 | 2×SO4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8q26.1.A | monomer | 0.91 | 1×GLY; 1×COA; 1×MG; | 100.00 | ||